Pay in 4 interest-free payments of $6.25 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
Our approach focuses on optimizing overall health, supporting metabolism, and helping uncover potential root causes for long-lasting, sustainable results
Clinical trial data from large cardiovascular outcome studiesincluding LEADER (liraglutide), SUSTAIN-6 (semaglutide), and REWIND (dulaglutide)have not demonstrated increased fracture risk among patients taking GLP-1 receptor agonists compared with placebo
Speak to our pharmacists at Centrum Pharmacy for current pricing based on your dose and coverage situation, as costs vary by pharmacy and plan
Article updated 12/17/2025 to reflect recent FDA communications, regulatory clarifications and clinical context related to GLP-1 medications
Statistical analysis Statistical analysis was performed with SPSS 21.0 for Windows (IBM, Armonk, NY, USA)
Read the full study: Metabolic studies of a synthetic lipolytic domain (AOD9604) of human growth hormone (Horm Res 2000)
US$ 22.40
US$ 27.37
US$ 21.13
